Generated by All in One SEO v4.8.5, this is an llms.txt file, used by LLMs to index the site. # Syntrix Pharmaceuticals ## Sitemaps - [XML Sitemap](https://syntrixbio.com/sitemap.xml): Contains all public/indexable URLs for this website. ## Posts - [Syntrix featured in the NIH Innovation Zone at 2014 Bio International Convention in San Diego, CA](https://syntrixbio.com/syntrix-featured-in-the-nih-innovation-zone-at-2014-bio-international-convention-in-san-diego-ca/) - [Syntrix wins U.S. patent 8,779,149: Aminopyridine and aminopyrimidine carboxamides as CXCR2 modulators](https://syntrixbio.com/syntrix-wins-u-s-patent-8779149-aminopyridine-and-aminopyrimidine-carboxamides-as-cxcr2-modulators/) - [Syntrix publication in Journal of Medicinal Chemistry](https://syntrixbio.com/syntrix-publication-in-journal-of-medicinal-chemistry/) - [Syntrix wins U.S. patent 8,969,365: Thiopyrimidinecarboxamides as CXCR1/2 modulators](https://syntrixbio.com/syntrix-wins-u-s-patent-8969365-thiopyrimidinecarboxamides-as-cxcr12-modulators/) - [Syntrix wins U.S. patent 8,981,106: Pyrimidinecarboxamides as CXCR2 modulators](https://syntrixbio.com/syntrix-wins-u-s-patent-8981106-pyrimidinecarboxamides-as-cxcr2-modulators/) - [Syntrix Wins U.S. Patent 8,993,541: Aminopyrimidine Carboxamides as CXCR2 Modulators](https://syntrixbio.com/syntrix-wins-u-s-patent-8993541-aminopyrimidine-carboxamides-as-cxcr2-modulators/) - [Syntrix Wins U.S. Patent 9,000,142: Photocleavable Sense-Antisense Complex](https://syntrixbio.com/syntrix-wins-u-s-patent-9000142-photocleavable-sense-antisense-complex/) - [Syntrix Publication in Bioorganic & Medicinal Chemistry Letters](https://syntrixbio.com/syntrix-publication-in-bioorganic-medicinal-chemistry-letters/) - [Syntrix wins U.S. patent 8,748,623: Pyridinecarboxamides as CXCR2 modulators](https://syntrixbio.com/syntrix-wins-u-s-patent-8748623-pyridinecarboxamides-as-cxcr2-modulators/) - [Syntrix Receives $1.725M Grant to Conduct a Phase II Clinical Trial Investigating Omnitram for the treatment of Diabetic Neuropathic Pain](https://syntrixbio.com/syntrix-receives-1-725m-grant-to-conduct-a-phase-ii-clinical-trial-investigating-omnitram-for-the-treatment-of-diabetic-neuropathic-pain/) - [Syntrix publication in Bioorganic & Medicinal Chemistry Letters](https://syntrixbio.com/syntrix-publication-in-bioorganic-medicinal-chemistry-letters-2/) - [Syntrix Opens Investigational New Drug (IND) Application for SX-682, a Dual CXCR1 and CXCR2 Inhibitor](https://syntrixbio.com/syntrix-opens-investigational-new-drug-ind-application-for-sx-682-a-dual-cxcr1-and-cxcr2-inhibitor/) - [Syntrix to Present at the 2016 Needham & Company 15th Annual Healthcare Conference](https://syntrixbio.com/syntrix-to-present-at-the-2016-needham-company-15th-annual-healthcare-conference/) - [Syntrix Receives $2.965M Grant to Conduct a Phase Ib Clinical Trial Investigating Omnitram for the Treatment of Pain in Patients Resistant to Tramadol](https://syntrixbio.com/syntrix-receives-2-965m-grant-to-conduct-a-phase-ib-clinical-trial-investigating-omnitram-for-the-treatment-of-pain-in-patients-resistant-to-tramadol/) - [Syntrix Wins U.S. Patent 9,480,694 – Thiopyrimidinecarboxamide for Use in Treating Pulmonary Disease](https://syntrixbio.com/syntrix-wins-u-s-patent-9480694-thiopyrimidinecarboxamide-for-use-in-treating-pulmonary-disease/) - [Study Published in Nature Provides Path for New Immunotherapy to Prostate Cancer Using SX-682 – Results Underpin Clinical Trial of SX-682 With Anti-PD1 and Anti-CTLA4 Combination](https://syntrixbio.com/study-published-in-nature-provides-path-for-new-immunotherapy-to-prostate-cancer-using-sx-682-results-underpin-clinical-trial-of-sx-682-with-anti-pd1-and-anti-ctla4-combination/) - [Syntrix Receives $2.3M Grant to Conduct a Phase 1/2 Clinical Trial Evaluating SX-682 Alone and with Pembrolizumab in Metastatic Melanoma](https://syntrixbio.com/syntrix-receives-2-3m-grant-to-conduct-a-phase-12-clinical-trial-evaluating-sx-682-alone-and-with-pembrolizumab-in-metastatic-melanoma/) - [Syntrix to Collaborate with NCI to Study SX-682 – Cooperative Research and Development Agreement (CRADA) Assesses SX-682 Alone and In Various Combinations](https://syntrixbio.com/syntrix-to-collaborate-with-nci-to-study-sx-682-cooperative-research-and-development-agreement-crada/) - [Syntrix Wins U.S. Patent 9,707,248 – Use of Thiopyrimidinecarboxamide for Treating Cancer](https://syntrixbio.com/syntrix-wins-u-s-patent-9707248-use-of-thiopyrimidinecarboxamide-for-treating-cancer/) - [Syntrix Wins Three U.S. Patents for Omnitram – 9,717,700; 9,717,701; 9,808,432](https://syntrixbio.com/syntrix-wins-three-u-s-patents-for-omnitram-9717700-9717701-9808432/) ## Pages - [Home](https://syntrixbio.com/) - [Contact Us](https://syntrixbio.com/contact-us/) - [Internship](https://syntrixbio.com/internship/) - [Careers](https://syntrixbio.com/pages/careers/) - [Partnering](https://syntrixbio.com/partnering/) - [Blog](https://syntrixbio.com/blog/) - [Team](https://syntrixbio.com/team/) - [Research](https://syntrixbio.com/research/) - [Immuno-Oncology](https://syntrixbio.com/pages/immuno-oncology/) - [404](https://syntrixbio.com/pages/page-not-found/) - [Pain](https://syntrixbio.com/pain/) - [Management](https://syntrixbio.com/pages/management/) - [Board of Directors](https://syntrixbio.com/board-directors/) - [About Syntrix](https://syntrixbio.com/pages/about-us/) - [Collaborators](https://syntrixbio.com/collaborators-2/) - [Scientific and Clinical Advisors and Collaborators](https://syntrixbio.com/collaborators/) - [Apply](https://syntrixbio.com/pages/apply/) - [Therapy Pipeline](https://syntrixbio.com/therapy-pipeline/) - [Maintenance Mode](https://syntrixbio.com/pages/maintenance-mode/) - [Our Services](https://syntrixbio.com/our-services/) ## Portfolio - [Spiderman](https://syntrixbio.com/?portfolio=spiderman) - [Desert Mini Planet](https://syntrixbio.com/?portfolio=desert-mini-planet) - [Savanna](https://syntrixbio.com/?portfolio=savanna) - [Geoz Collide](https://syntrixbio.com/?portfolio=geez-collide) - [The Vikings](https://syntrixbio.com/?portfolio=the-vikings) - [The Elephant](https://syntrixbio.com/?portfolio=elephant) - [Geo Planetz](https://syntrixbio.com/?portfolio=geo-planetz) - [Elk](https://syntrixbio.com/?portfolio=elk) - [Underwater](https://syntrixbio.com/?portfolio=underwater) - [Ronin](https://syntrixbio.com/?portfolio=ronin) - [In The Woods](https://syntrixbio.com/?portfolio=in-the-woods) - [The Journey](https://syntrixbio.com/?portfolio=the-forest) ## Galleries - [Gallery Three](https://syntrixbio.com/?galleries=gallery-three) - [Gallery Two](https://syntrixbio.com/?galleries=gallery-two) - [Gallery One](https://syntrixbio.com/?galleries=gallery-one) ## Team - [John A. Zebala, MD, PhD](https://syntrixbio.com/?team=john-zebola) - [Mark Mendel, PhD](https://syntrixbio.com/?team=mark-mendel) - [Larry Fritz, PhD](https://syntrixbio.com/?team=larry-fritz) - [McGarry Houghton, MD](https://syntrixbio.com/?team=mcgarry-houghton-m-d) - [William Schmidt, PhD](https://syntrixbio.com/?team=william-schmidt-md) - [David Linehan, MD](https://syntrixbio.com/?team=david-linehan-md) - [Robert Dworkin, MD](https://syntrixbio.com/?team=robert-dworkin-md) - [Elizabeth Mittendorf, MD, PhD](https://syntrixbio.com/?team=elizabeth-mittendorf-m-d-ph-d) - [Nat Katz, MD, MS](https://syntrixbio.com/?team=nat-katz-md) - [Jeffrey Schlom, PhD](https://syntrixbio.com/?team=jeffrey-schlom-ph-d) - [Rami Komrokji, MD](https://syntrixbio.com/?team=alan-list-m-d) - [Dimitry Gabrilovitch, MD, PhD](https://syntrixbio.com/?team=dimitry-gabrilovitch-m-d-phd) - [Keith Flaherty, MD](https://syntrixbio.com/?team=keith-flaherty-m-d) - [Ronald DePinho, MD](https://syntrixbio.com/?team=ronald-depinho) - [Stuart Kahn, MD](https://syntrixbio.com/?team=stuart-kahn) - [Martin “Mac” Cheever, MD](https://syntrixbio.com/?team=martin-mac-cheever) - [Dean Y. Maeda, PhD](https://syntrixbio.com/?team=dean-y-maeda) ## Clients - [Codepen](https://syntrixbio.com/?clients=codepen) - [Github](https://syntrixbio.com/?clients=github) - [VOD](https://syntrixbio.com/?clients=vod) - [Dribbble](https://syntrixbio.com/?clients=dribbble) - [WordPress](https://syntrixbio.com/?clients=wordpress) - [jQuery](https://syntrixbio.com/?clients=jquery) - [Vimeo Pro](https://syntrixbio.com/?clients=vimeo-pro) - [Envato](https://syntrixbio.com/?clients=envato) ## FAQs - [What does it cost?](https://syntrixbio.com/?faqs=what-does-it-cost) ## Directory - [Rome](https://syntrixbio.com/?directory=new-york) - [London](https://syntrixbio.com/?directory=london) - [Paris](https://syntrixbio.com/?directory=paris) ## SPB Sections - [Promo Bar: Basic](https://syntrixbio.com/?spb-section=promo-bar-basic) - [Promo Bar + Button (aligned)](https://syntrixbio.com/?spb-section=promo-bar-button-aligned) - [Promo Bar + Button](https://syntrixbio.com/?spb-section=promo-bar-button) - [Counters x4](https://syntrixbio.com/?spb-section=counters-x4) - [Promo Animated Headline](https://syntrixbio.com/?spb-section=promo-animated-headline) - [Sign Up Bar](https://syntrixbio.com/?spb-section=sign-up-bar) - [Testimonials Grid](https://syntrixbio.com/?spb-section=testimonials-grid) - [Testimonials Showcase Row](https://syntrixbio.com/?spb-section=testimonials-showcase-row) - [Testimonials Showcase](https://syntrixbio.com/?spb-section=testimonials-showcase) - [Icons: centrered: 3x2](https://syntrixbio.com/?spb-section=icons-centrered-3x2) - [Port Showcase: Dark](https://syntrixbio.com/?spb-section=port-showcase-dark) - [Icons: 3x2 vert svg](https://syntrixbio.com/?spb-section=icons-3x2-vert-svg) - [Icons: Animated: 3x1](https://syntrixbio.com/?spb-section=icons-animated-3x1) - [Icons: Standard: Uncontained: 3x2](https://syntrixbio.com/?spb-section=icons-standard-uncontained-3x2) - [Icon Grid: Light: 3x2](https://syntrixbio.com/?spb-section=icon-grid-light-3x2) ## Categories - [News](https://syntrixbio.com/category/news/) ## Tags - [Management](https://syntrixbio.com/tag/management/) - [board](https://syntrixbio.com/tag/board/) - [collaborators](https://syntrixbio.com/tag/collaborators/) - [CLINICAL TRIAL](https://syntrixbio.com/tag/clinical-trial/) - [NIDA](https://syntrixbio.com/tag/nida/) - [NIH](https://syntrixbio.com/tag/nih/) - [OMNITRAM](https://syntrixbio.com/tag/omnitram/) - [SYNTRIX BIOSYSTEMS](https://syntrixbio.com/tag/syntrix-biosystems/) - [TRAMADOL](https://syntrixbio.com/tag/tramadol/) ## Slide Categories - [agency](https://syntrixbio.com/?swift-slider-category=agency) - [blog](https://syntrixbio.com/?swift-slider-category=blog) - [home](https://syntrixbio.com/?swift-slider-category=home) - [portfolio](https://syntrixbio.com/?swift-slider-category=portfolio) - [poster](https://syntrixbio.com/?swift-slider-category=poster) - [product](https://syntrixbio.com/?swift-slider-category=product) - [immuno](https://syntrixbio.com/?swift-slider-category=immuno) - [pain](https://syntrixbio.com/?swift-slider-category=pain) ## Portfolio Categories - [Blender](https://syntrixbio.com/portfolio-category/blender/) - [Dark](https://syntrixbio.com/portfolio-category/dark/) - [Illustration](https://syntrixbio.com/portfolio-category/illustration/) - [Light](https://syntrixbio.com/portfolio-category/light/) - [Visualisation](https://syntrixbio.com/portfolio-category/visualisation/) ## Team Categories - [management](https://syntrixbio.com/team-category/management/) - [Board](https://syntrixbio.com/team-category/board/) - [collaborators](https://syntrixbio.com/team-category/collaborators/) ## Topics - [General](https://syntrixbio.com/faqs-category/general/)